Literature DB >> 32462559

Cancer mortality risk, fine particulate air pollution, and smoking in a large, representative cohort of US adults.

Nathan C Coleman1, Richard T Burnett2, Joshua D Higbee3, Jacob S Lefler4, Ray M Merrill5, Majid Ezzati6, Julian D Marshall7, Sun-Young Kim8, Matthew Bechle7, Allen L Robinson9, C Arden Pope10.   

Abstract

PURPOSE: Air pollution and smoking are associated with various types of mortality, including cancer. The current study utilizes a publicly accessible, nationally representative cohort to explore relationships between fine particulate matter (PM2.5) exposure, smoking, and cancer mortality.
METHODS: National Health Interview Survey and mortality follow-up data were combined to create a study population of 635,539 individuals surveyed from 1987 to 2014. A sub-cohort of 341,665 never-smokers from the full cohort was also created. Individuals were assigned modeled PM2.5 exposure based on average exposure from 1999 to 2015 at residential census tract. Cox Proportional Hazard models were utilized to estimate hazard ratios for cancer-specific mortality controlling for age, sex, race, smoking status, body mass, income, education, marital status, rural versus urban, region, and survey year.
RESULTS: The risk of all cancer mortality was adversely associated with PM2.5 (per 10 µg/m3 increase) in the full cohort (hazard ratio [HR] 1.15, 95% confidence interval [CI] 1.08-1.22) and the never-smokers' cohort (HR 1.19, 95% CI 1.06-1.33). PM2.5-morality associations were observed specifically for lung, stomach, colorectal, liver, breast, cervix, and bladder, as well as Hodgkin lymphoma, non-Hodgkin lymphoma, and leukemia. The PM2.5-morality association with lung cancer in never-smokers was statistically significant adjusting for multiple comparisons. Cigarette smoking was statistically associated with mortality for many cancer types.
CONCLUSIONS: Exposure to PM2.5 air pollution contributes to lung cancer mortality and may be a risk factor for other cancer types. Cigarette smoking has a larger impact on cancer mortality than PM2.5 , but is associated with similar cancer types.

Entities:  

Keywords:  Air pollution; Cancer; Mortality; PM2.5; Smoking

Mesh:

Substances:

Year:  2020        PMID: 32462559     DOI: 10.1007/s10552-020-01317-w

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  18 in total

1.  Long-term exposure to ambient air pollution and bladder cancer incidence in a pooled European cohort: the ELAPSE project.

Authors:  Ole Raaschou-Nielsen; Gerard Hoek; Jie Chen; Sophia Rodopoulou; Maciej Strak; Kees de Hoogh; Tahir Taj; Aslak Harbo Poulsen; Zorana J Andersen; Tom Bellander; Jørgen Brandt; Emanuel Zitt; Daniela Fecht; Francesco Forastiere; John Gulliver; Ole Hertel; Barbara Hoffmann; Ulla Arthur Hvidtfeldt; W M Monique Verschuren; Jeanette T Jørgensen; Klea Katsouyanni; Matthias Ketzel; Anton Lager; Karin Leander; Shuo Liu; Petter Ljungman; Gianluca Severi; Marie-Christine Boutron-Ruault; Patrik K E Magnusson; Gabriele Nagel; Göran Pershagen; Annette Peters; Debora Rizzuto; Yvonne T van der Schouw; Evangelia Samoli; Mette Sørensen; Massimo Stafoggia; Anne Tjønneland; Gudrun Weinmayr; Kathrin Wolf; Bert Brunekreef
Journal:  Br J Cancer       Date:  2022-02-16       Impact factor: 9.075

Review 2.  Cohort studies of long-term exposure to outdoor particulate matter and risks of cancer: A systematic review and meta-analysis.

Authors:  Pei Yu; Suying Guo; Rongbin Xu; Tingting Ye; Shanshan Li; Malcolm R Sim; Michael J Abramson; Yuming Guo
Journal:  Innovation (Camb)       Date:  2021-07-13

3.  [Smoking, vaping among hospital staff during the Covid-19 pandemic: Appraisal of the "tobacco-free hospital, campus" campaign in Brest].

Authors:  R Pougnet; D Lucas; L Pougnet; D Chapalain; C Fortin; B Loddé; J D Dewitte; M B Eniafe-Eveillard; V Le Denmat
Journal:  Rev Mal Respir       Date:  2022-02-16       Impact factor: 0.714

4.  Fine Particulate Matter Exposure and Cancer Incidence: Analysis of SEER Cancer Registry Data from 1992-2016.

Authors:  Nathan C Coleman; Richard T Burnett; Majid Ezzati; Julian D Marshall; Allen L Robinson; C Arden Pope
Journal:  Environ Health Perspect       Date:  2020-10-09       Impact factor: 9.031

5.  Fine Particulate Matter Air Pollution and Mortality Risk Among US Cancer Patients and Survivors.

Authors:  Nathan C Coleman; Majid Ezzati; Julian D Marshall; Allen L Robinson; Richard T Burnett; C Arden Pope
Journal:  JNCI Cancer Spectr       Date:  2021-02-21

Review 6.  Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations.

Authors:  Michelle C Turner; Zorana J Andersen; Andrea Baccarelli; W Ryan Diver; Susan M Gapstur; C Arden Pope; Diddier Prada; Jonathan Samet; George Thurston; Aaron Cohen
Journal:  CA Cancer J Clin       Date:  2020-08-25       Impact factor: 508.702

7.  Calling Attention to the Role of Race-Driven Societal Determinants of Health on Aggressive Tumor Biology: A Focus on Black Americans.

Authors:  Kimlin T Ashing; Veronica Jones; Fornati Bedell; Tanyanika Phillips; Loretta Erhunmwunsee
Journal:  JCO Oncol Pract       Date:  2021-07-13

8.  The association between ambient air pollutants and pancreatic cancer in the Multiethnic Cohort Study.

Authors:  David Bogumil; Anna H Wu; Daniel Stram; Juan Yang; Chiu-Chen Tseng; Loïc Le Marchand; Jun Wu; Iona Cheng; Veronica Wendy Setiawan
Journal:  Environ Res       Date:  2021-06-30       Impact factor: 6.498

9.  Ambient air pollution and ovarian cancer survival in California.

Authors:  Carolina Villanueva; Jenny Chang; Argyrios Ziogas; Robert E Bristow; Verónica M Vieira
Journal:  Gynecol Oncol       Date:  2021-07-28       Impact factor: 5.304

10.  Association of Ambient Fine Particulate Matter (PM2.5) with Elevated Fecal Hemoglobin Concentration and Colorectal Carcinogenesis: A Population-Based Retrospective Cohort Study.

Authors:  Mei-Sheng Ku; Chen-Yu Liu; Chen-Yang Hsu; Han-Mo Chiu; Hsiu-Hsi Chen; Chang-Chuan Chan
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.